The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy
Abstract
S-adenosylmethionine (SAMe) is involved in many transmethylation reactions in most living organisms and is also required in the synthesis of several substances such as monoamine neurotransmitters and the N-methyl-D-aspartate (NMDA) receptor. Due to its important role as an epigenetic modulator, we discuss in some length the process of DNA methylation and demethylation and the critical periods of epigenetic modifications in the embryo, fetus, and thereafter. We also discuss the effects of SAMe deficiency and the attempts to use SAMe for therapeutic purposes such as the treatment of major depressive disorder, Alzheimer disease, and other neuropsychiatric disorders. SAMe is an approved food additive and as such is also used during pregnancy. Yet, there seems to scanty data on the possible effects of SAMe on the developing embryo and fetus. Valproic acid (VPA) is a well-tolerated and effective antiepileptic drug that is also used as a mood stabilizer. Due to its high teratogenicity, it is contraindicated in pregnancy. A major mechanism of its action is histone deacetylase inhibition, and therefore, it acts as an epigenetic modulator, mainly on the brain. This prompted clinical trials using VPA for additional indications i.e., treating degenerative brain disease such as Alzheimer disease, dementia, HIV, and even cancer. Therefore, we discuss the possible effects of VPA and SAMe on the conceptus and early postnatally, during periods of susceptibility to epigenetic modifications. VPA is also used as an inducer of autistic-like behavior in rodents and was found by us to modify gene expression when administered during the first postnatal week but not when administered to the pregnant dams on day 12 of gestation. In contrast, SAMe modified gene expression when administered on day 12 of pregnancy but not postnatally. If administered together, VPA prevented the changes in gene expression induced by prenatal SAMe administration, and SAMe prevented the gene expression changes and autistic-like behavior induced by early postnatal VPA. It is concluded that both VPA and SAMe are powerful epigenetic modifiers with antagonistic actions on the brain that will probably be used in the future more extensively for the treatment of a variety of epigenetic diseases of the nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposing pregnant rodents to VPA has been established as a modeling tool for studying ASD-like behavior [49,66,67].”
From Animal Models of Autistic-like Behavior in Rodents: A Scoping Review and Call for a Comprehensive Scoring System (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · cited 2×
“VPA causes histone deacetylase inhibition [111,112], resulting in teratogenicity and cell toxicity.”
BackgroundResultPrenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526
Self-citationShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485 · cited 1×
“Some studies have demonstrated in depressed patients abnormal oxidative product levels in the peripheral blood [78,79], red blood cells (RBC) [79,80], mononuclear cells [79], urine [81], cerebrospinal fluid [82], and postmortem brains [82].”
BackgroundRose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., & James, S. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.61 · Cited by 480
CpG and non-CpG methylation in epigenetic gene regulation and brain function
Jang, H., Shin, W., Lee, J., & Do, J. (2017) · Genes · doi:10.3390/genes8060148 · Cited by 427
Kataoka, S., Takuma, K., Hara, Y., Maeda, Y., Ago, Y., & Matsuda, T. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001714 · Cited by 341
Loss of Tet Enzymes Compromises Proper Differentiation of Embryonic Stem Cells
Dawlaty, M. M., Breiling, A., Le, T., Barrasa, M. I., Raddatz, G., Gao, Q., Powell, B. E., Cheng, A. W., Faull, K. F., Lyko, F., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.03.003 · Cited by 338
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Markers of Oxidative Stress and Neuroprogression in Depression Disorder
Vaváková, M., Ďuračková, Z., & Trebatická, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/898393 · Cited by 324
Bottiglieri, T. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1151s · Cited by 286
Role of S-adenosyl-l-methionine in the treatment of depression: a review of the evidence,,,
Mischoulon, D., & Fava, M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.1158s · Cited by 285
Prenatal factors associated with autism spectrum disorder (ASD)
Ornoy, A., Weinstein-Fudim, L., & Ergaz, Z. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.05.007 · Cited by 238 · cited 1×
“Epigenetic mechanisms are currently related not only to a variety of biological and developmental processes but also in the pathogenetic mechanisms of a variety of congenital malformations and diseases, including many neurobehavioral and psychiatric disorders [1,2].”
BackgroundSelf-citationAntioxidants as potential therapeutics for neuropsychiatric disorders
Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222
Mitochondrial abnormalities in temporal lobe of autistic brain
Tang, G., Gutierrez Rios, P., Kuo, S.-H., Akman, H. O., Rosoklija, G., Tanji, K., Dwork, A., Schon, E. A., DiMauro, S., Goldman, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.006 · Cited by 194
Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172
Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165 · cited 1×
“The brain is considered as particularly vulnerable to oxidative damage due to its high oxygen consumption, low antioxidant defense, and large amounts of oxidation-sensitive lipids [73,74].”
BackgroundGhezzo, A., Visconti, P., Abruzzo, P. M., Bolotta, A., Ferreri, C., Gobbi, G., Malisardi, G., Manfredini, S., Marini, M., Nanetti, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066418 · Cited by 164
Rybka, J., Kędziora-Kornatowska, K., Banaś-Leżańska, P., Majsterek, I., Carvalho, L. A., Cattaneo, A., Anacker, C., & Kędziora, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.019 · Cited by 146
MeCP2: the long trip from a chromatin protein to neurological disorders
Ausió, J., Paz, A. M. D., & Esteller, M. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.004 · Cited by 108
Roost, M. S., Slieker, R. C., Bialecka, M., van Iperen, L., Gomes Fernandes, M. M., He, N., Suchiman, H. E. D., Szuhai, K., Carlotti, F., de Koning, E. J. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01077-3 · Cited by 65 · cited 1×
“The analysis of multiple isogenic organ sets showed that organ-specific DNA methylation patterns were highly dynamic in the human embryo between week 9 (W9) and W22 of gestation [34], at gestational ages when different immature organ systems are sensitive to functional defects.”
BackgroundFancourt, D., & Steptoe, A. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.10.004 · Cited by 57
Research works printed but not linked: 115
- Szyf, 2015, Prospects for the development of epigenetic drugs for CNS conditions, Nat. Rev. Drug Discov., 14, 461, 10.1038/nrd4580 · DOI
- Finkelstein, 1990, Methionine metabolism in mammals, J. Nutr. Biochem., 1, 228, 10.1016/0955-2863(90)90070-2 · DOI · Paper page
- Lu, 2000, S-Adenosylmethionine, Int. J. Biochem. Cell Boil., 32, 391, 10.1016/S1357-2725(99)00139-9 · DOI · Paper page
- Miller, 1997, Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats, Clin. Neuropharmacol., 20, 55, 10.1097/00002826-199702000-00007 · DOI
- Cheng, 1997, Levels ofl-MethionineS-Adenosyltranferase Activity in Erythrocytes and Concentrations ofS-Adenosylmethionine andS-Adenosylhomocysteine in Whole Blood of Patients with Parkinson’s Disease, Exp. Neurol., 145, 580, 10.1006/exnr.1997.6466 · DOI
- Surtees, 1990, L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans, J. Neurol. Neurosurg. Psychiatry, 53, 569, 10.1136/jnnp.53.7.569 · DOI
- Mato, 1997, S-adenosylmethionine synthesis: Molecular mechanisms and clinical implications, Pharmacol. Ther., 73, 265, 10.1016/S0163-7258(96)00197-0 · DOI · Paper page
- Ragnarsson, 2002, Spermine modulation of the glutamate NMDA receptor is differentially responsive to conantokins in normal and Alzheimer’s disease human cerebral cortex, J. Neurochem., 81, 765, 10.1046/j.1471-4159.2002.00872.x · DOI
- Mudd, 1975, Labile methyl balances for normal humans on various dietary regimens, Metabolism, 24, 721, 10.1016/0026-0495(75)90040-2 · DOI · Paper page
- Chen, 2011, DNA methylation and demethylation in mammals, J. Boil. Chem., 286, 18347, 10.1074/jbc.R110.205286 · DOI · Paper page
- Sharp, 2011, DNA methylation profiles of human active and inactive X chromosomes, Genome Res., 21, 1592, 10.1101/gr.112680.110 · DOI · Paper page
- Hanson, 2015, Developmental origins of health and disease--global public health implications, Best Pract. Res. Clin. Obstet. Gynaecol., 29, 24, 10.1016/j.bpobgyn.2014.06.007 · DOI · Paper page
- Kuijper, 2019, Developing differences: early-life effects and evolutionary medicine, Philos. Trans. R. Soc. B Boil. Sci., 374, 20190039, 10.1098/rstb.2019.0039 · DOI
- Okano, 1998, Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases, Nat. Genet., 19, 219, 10.1038/890 · DOI · Paper page
- Jeltsch, 2016, Allosteric control of mammalian DNA methyltransferases - a new regulatory paradigm, Nucleic Acids Res., 44, 8556, 10.1093/nar/gkw723 · DOI · Paper page
- Jeltsch, 2008, Reading and writing DNA methylation, Nat. Struct. Mol. Boil., 15, 1003, 10.1038/nsmb1008-1003 · DOI
- Cheng, 2008, Mammalian DNA Methyltransferases: A Structural Perspective, Structure, 16, 341, 10.1016/j.str.2008.01.004 · DOI · Paper page
- Hermann, 2004, Biochemistry and biology of mammalian DNA methyltransferases, Cell. Mol. Life Sci., 61, 2571, 10.1007/s00018-004-4201-1 · DOI · Paper page
- Nan, 1998, Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex, Nature, 393, 386, 10.1038/30764 · DOI · Paper page
- Bestor, 1998, Methylation meets acetylation, Nature, 393, 311, 10.1038/30613 · DOI
- Kimura, 2013, Histone modifications for human epigenome analysis, J. Hum. Genet., 58, 439, 10.1038/jhg.2013.66 · DOI · Paper page
- Kyriakou, 2019, Histone Modifications as an Intersection Between Diet and Longevity, Front. Genet., 10, 192, 10.3389/fgene.2019.00192 · DOI
- Bannister, 2011, Regulation of chromatin by histone modifications, Cell Res., 21, 381, 10.1038/cr.2011.22 · DOI · Paper page
- Tan, 2012, Tet family proteins and 5-hydroxymethylcytosine in development and disease, Development, 139, 1895, 10.1242/dev.070771 · DOI · Paper page
- An, 2017, TET family dioxygenases and DNA demethylation in stem cells and cancers, Exp. Mol. Med., 49, e323, 10.1038/emm.2017.5 · DOI · Paper page
- Nagy, 2012, Sensitive periods in epigenetics: Bringing us closer to complex behavioral phenotypes, Epigenomics, 4, 445, 10.2217/epi.12.37 · DOI · Paper page
- Lee, 2014, Reprogramming the methylome: erasing memory and creating diversity, Cell Stem Cell, 14, 710, 10.1016/j.stem.2014.05.008 · DOI · Paper page
- Nguyen, 2007, Ablation of de novo DNA methyltransferase Dnmt3a in the nervous system leads to neuromuscular defects and shortened lifespan, Dev. Dyn., 236, 1663, 10.1002/dvdy.21176 · DOI · Paper page
- Reizel, 2018, Postnatal DNA demethylation and its role in tissue maturation, Nat. Commun., 9, 2040, 10.1038/s41467-018-04456-6 · DOI · Paper page
- Almstrup, 2016, Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood, Sci. Rep., 6, 28657, 10.1038/srep28657 · DOI
- Yuan, X., Li, Z., Ye, S., Chen, Z., Huang, S., Zhong, Y., Zhang, H., Li, J., and Zhang, Z. (2019). Genome-wide DNA methylation analysis of pituitaries during the initiation of puberty in gilts. PLoS ONE, 14. · DOI
- Altman, 1993, Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat, NeuroToxicology, 14, 83
- Rice, 2000, Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models, Environ. Health Perspect., 108, 511
- Semple, 2013, Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species, Prog. Neurobiol., 106, 1, 10.1016/j.pneurobio.2013.04.001 · DOI · Paper page
- Murphy, 2014, Oral SAMe in Persistent Treatment-Refractory Bipolar Depression, J. Clin. Psychopharmacol., 34, 413, 10.1097/JCP.0000000000000064 · DOI
- Wilson, 2019, S-Adenosyl Methionine (SAMe) for Depression in Adults, Issues Ment. Heal. Nurs., 40, 725, 10.1080/01612840.2017.1392161 · doi:10.1080/01612840.2017.1392161
- Hoffmann, A., Sportelli, V., Ziller, M., and Spengler, D. (2017). Epigenomics of Major Depressive Disorders and Schizophrenia: Early Life Decides. Int. J. Mol. Sci., 18. · DOI
- Orsolini, 2016, A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder, CNS Neurol. Disord.-Drug Targets, 15, 35, 10.2174/1871527314666150821103825 · DOI
- Jacobsen, 1991, Oral S-adenosylmethionine in Primary Fibromyalgia. Double-blind Clinical Evaluation, Scand. J. Rheumatol., 20, 294, 10.3109/03009749109096803 · DOI
- Berger, 1987, A new medical approach to the treatment of osteoarthritis. Report of an open phase IV study with ademetionine (Gumbaral), Am. J. Med., 83, 84, 10.1016/0002-9343(87)90858-8 · doi:10.1016/0002-9343(87)90858-8
- Friedel, 1989, S-Adenosyl-L-Methionine, Drugs, 38, 389, 10.2165/00003495-198938030-00004 · DOI · Paper page
- Perez, 2003, Effects of S-adenosylmethionine on hepatic regeneration after partial hepatectomy in the rat, J. Physiol. Biochem., 59, 63, 10.1007/BF03179869 · doi:10.1007/bf03179869
- Purohit, 2007, Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium, Am. J. Clin. Nutr., 86, 14, 10.1093/ajcn/86.1.14 · DOI · Paper page
- Papakostas, 2010, S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial, Am. J. Psychiatry, 167, 942, 10.1176/appi.ajp.2009.09081198 · DOI · Paper page
- Sarris, 2018, Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial, Eur. Neuropsychopharmacol., 28, 1126, 10.1016/j.euroneuro.2018.07.098 · DOI
- McCoy, 2016, Genetic predisposition to high anxiety- and depression-like behavior coincides with diminished DNA methylation in the adult rat amygdala, Behav. Brain Res., 320, 165, 10.1016/j.bbr.2016.12.008 · DOI
- McCoy, 2018, A paternal methyl donor depleted diet leads to increased anxiety- and depression-like behavior in adult rat offspring, Biosci. Rep., 38, 20180730, 10.1042/BSR20180730 · DOI
- Darby, 2016, Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders, Transl. Psychiatry, 6, e890, 10.1038/tp.2016.173 · DOI
- Saunderson, 2016, Stress-induced gene expression and behavior are controlled by DNA methylation and methyl donor availability in the dentate gyrus, Proc. Natl. Acad. Sci. USA, 113, 4830, 10.1073/pnas.1524857113 · DOI
- Song, 2005, S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor, Biochim. Biophys. Acta (BBA) Bioenergy, 1743, 205, 10.1016/j.bbamcr.2004.12.001 · DOI
- Gobejishvili, 2011, S-adenosylmethionine decreases lipopolysaccharide-induced phosphodiesterase 4B2 and attenuates tumor necrosis factor expression via cAMP/protein kinase A pathway, J. Pharmacol. Exp. Ther., 337, 433, 10.1124/jpet.110.174268 · DOI
- Xia, 2008, S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation, Hepatology, 47, 1655, 10.1002/hep.22231 · DOI
- Folstein, 2007, The homocysteine hypothesis of depression, Am. J. Psychiatry, 164, 861, 10.1176/ajp.2007.164.6.861 · DOI · Paper page
- Jakubowski, 2002, Homocysteine Is a Protein Amino Acid in Humans, J. Boil. Chem., 277, 30425, 10.1074/jbc.C200267200 · DOI · Paper page
- Škovierová, H., Vidomanová, E., Mahmood, S., Sopková, J., Drgová, A., Červeňová, T., Halasova, E., and Lehotsky, J. (2016). The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health. Int. J. Mol. Sci., 17. · DOI · Paper page
- Stanger, 2009, Homocysteine, folate and vitamin B12in neuropsychiatric diseases: review and treatment recommendations, Expert Rev. Neurother., 9, 1393, 10.1586/ern.09.75 · DOI · Paper page
- Bottiglieri, 2000, Homocysteine, folate, methylation, and monoamine metabolism in depression, J. Neurol. Neurosurg. Psychiatry, 69, 228, 10.1136/jnnp.69.2.228 · DOI · Paper page
- Morris, 2003, Depression and folate status in the US Population, Psychother. Psychosom., 72, 80, 10.1159/000068692 · DOI · Paper page
- Hintikka, J., Tolmunen, T., Tanskanen, A., and Viinamäki, H. (2003). High vitamin B12 level and good treatment outcome may be associated in major depressive disorder. BMC Psychiatry, 3. · DOI
- Ornoy, 2007, Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy, Reprod. Toxicol, 24, 31, 10.1016/j.reprotox.2007.04.004 · DOI · Paper page
- Sarandol, 2007, Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative–antioxidative systems, Hum. Psychopharmacol. Clin. Exp., 22, 67, 10.1002/hup.829 · DOI · Paper page
- Sorce, 2009, NOX Enzymes in the Central Nervous System: From Signaling to Disease, Antioxid. Redox Signal., 11, 2481, 10.1089/ars.2009.2578 · DOI · Paper page
- Bilici, 2001, Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments, J. Affect. Disord., 64, 43, 10.1016/S0165-0327(00)00199-3 · DOI · Paper page
- Milaneschi, Y., Cesari, M., Simonsick, E.M., Vogelzangs, N., Kanaya, A.M., Yaffe, K., Patrignani, P., Metti, A., Kritchevsky, S.B., and Pahor, M. (2013). Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women. PLoS ONE, 8. · DOI
- Gao, 2012, Decreased NOS1 Expression in the Anterior Cingulate Cortex in Depression, Cereb. Cortex, 23, 2956, 10.1093/cercor/bhs285 · DOI
- Adams, 2009, The Severity of Autism Is Associated with Toxic Metal Body Burden and Red Blood Cell Glutathione Levels, J. Toxicol., 2009, 1, 10.1155/2009/532640 · DOI
- Huang, 2011, Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats, Neurosci. Lett., 493, 145, 10.1016/j.neulet.2011.02.030 · DOI
- Kulkarni, 2008, Antidepressant activity of curcumin: involvement of serotonin and dopamine system, Psychopharmacol., 201, 435, 10.1007/s00213-008-1300-y · DOI · Paper page
- Bouayed, 2007, Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects, J. Neurol. Sci., 262, 77, 10.1016/j.jns.2007.06.028 · DOI · Paper page
- Banji, 2011, Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals, Brain Res., 1410, 141, 10.1016/j.brainres.2011.06.063 · DOI
- Abdulla, 2013, Natural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro, J. Biochem. Pharmacol. Res., 1, 56
- Pragnya, 2014, Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice, Behav. Brain Res., 270, 86, 10.1016/j.bbr.2014.04.045 · DOI
- Yang, C., Bosker, F.J., Li, J., and Schoevers, R.A. (2018). N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial. BMC Psychiatry, 18. · DOI
- Hasebe, 2017, Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor, Acta Neuropsychiatr., 29, 337, 10.1017/neu.2017.2 · DOI
- Cederbaum, 2010, Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury, World J. Gastroenterol., 16, 1366, 10.3748/wjg.v16.i11.1366 · DOI
- Lieber, 1990, S-Adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon, Hepatology, 11, 165, 10.1002/hep.1840110203 · DOI · Paper page
- Guo, T., Chang, L., Xiao, Y., and Liu, Q. (2015). S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis. PLoS ONE, 10. · DOI
- Fuso, 2012, S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice, Neurobiol. Aging, 33, 1482.e1, 10.1016/j.neurobiolaging.2011.12.013 · DOI
- Cavallaro, R.A., Nicolia, V., Fiorenza, M.T., Scarpa, S., and Fuso, A. (2017). S-Adenosylmethionine and Superoxide Dismutase 1 Synergistically Counteract Alzheimer’s Disease Features Progression in TgCRND8 Mice. Antioxidants, 6. · DOI
- Li, 2017, S-Adenosylmethionine Attenuates Oxidative Stress and Neuroinflammation Induced by Amyloid-β Through Modulation of Glutathione Metabolism, J. Alzheimer’s Dis., 58, 549, 10.3233/JAD-170177 · DOI
- Cavallaro, 2010, S-Adenosylmethionine Prevents Oxidative Stress and Modulates Glutathione Metabolism in TgCRND8 Mice Fed a B-Vitamin Deficient Diet, J. Alzheimer’s Dis., 20, 997, 10.3233/JAD-2010-091666 · DOI
- Persichilli, 2015, Plasma Thiols Levels in Alzheimer’s Disease Mice under Diet-Induced Hyperhomocysteinemia: Effect of S-Adenosylmethionine and Superoxide-Dismutase Supplementation, J. Alzheimer’s Dis., 44, 1323, 10.3233/JAD-142391 · DOI
- Bialer, 2012, Why are antiepileptic drugs used for nonepileptic conditions?, Epilepsia, 53, 26, 10.1111/j.1528-1167.2012.03712.x · DOI · Paper page
- Johannessen, 2006, Valproate: Past, Present, and Future, CNS Drug Rev., 9, 199, 10.1111/j.1527-3458.2003.tb00249.x · DOI · Paper page
- Ghodke, 2013, Valproic acid pathway: Pharmacokinetics and pharmacodynamics, Pharmacogenet. Genom., 23, 236, 10.1097/FPC.0b013e32835ea0b2 · DOI · Paper page
- Zou, 2016, Upregulation of CD54 and downregulation of HLA-ABC contribute to the novel enhancement of the susceptibility of HL-60 cells to NK cell-mediated cytolysis induced by ATRA plus VPA, Oncol. Rep., 37, 105, 10.3892/or.2016.5212 · DOI
- Nakashima, H., Oniki, K., Nishimura, M., Ogusu, N., Shimomasuda, M., Ono, T., Matsuda, K., Yasui-Furukori, N., Nakagawa, K., and Ishitsu, T. (2015). Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis. PLoS ONE, 10. · DOI
- Terbach, 2009, Structure–function studies for the panacea, valproic acid, Biochem. Soc. Trans., 37, 1126, 10.1042/BST0371126 · DOI
- Sixto-López, Y., Bello, M., and Correa-Basurto, J. (2020). Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach. J. Comput. Aided Mol. Des. · DOI
- Chanda, 2019, Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity, Cell Stem Cell, 25, 103, 10.1016/j.stem.2019.04.021 · DOI
- Moldrich, 2013, Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice, Behav. Brain Res., 257, 253, 10.1016/j.bbr.2013.09.049 · DOI
- Qing, 2008, Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer’s disease mouse models, J. Exp. Med., 205, 2781, 10.1084/jem.20081588 · DOI · Paper page
- Noh, 2014, Age-dependent effects of valproic acid in Alzheimer’s disease (AD) mice are associated with nerve growth factor (NGF) regulation, Neuroscience, 266, 255, 10.1016/j.neuroscience.2014.02.012 · DOI
- Dedoni, 2019, Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors, J. Pharmacol. Exp. Ther., 370, 490, 10.1124/jpet.119.258129 · DOI
- Kavoosi, 2019, Effect of 5-aza-2’-deoxycytidine in comparison to valproic acid and trichostatin a on histone deacetylase 1, dna methyltransferase 1, and cip/kip family (p21, p27, and p57) genes expression, cell growth inhibition, and apoptosis induction in colon cancer sw480 cell line, Adv. Biomed. Res., 8, 52, 10.4103/abr.abr_91_19 · doi:10.4103/abr.abr_91_19
- Chen, 2017, Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1, Boil. Chem., 398, 785, 10.1515/hsz-2016-0307 · DOI
- Montani, 2017, Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells, Cell. Oncol., 40, 167, 10.1007/s13402-017-0314-z · DOI
- Crosby, 2018, Repurposing medications for use in treating HIV infection: A focus on valproic acid as a latency-reversing agent, J. Clin. Pharm. Ther., 43, 740, 10.1111/jcpt.12726 · doi:10.1111/jcpt.12726
- Ribalta, 1991, S-Adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: A randomized, double-blind, placebo-controlled study with negative results, Hepatology, 13, 1084
- Puerta, 1998, [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats], Nutrición Hospitalaria, 13, 41
- Seyoum, 1994, In vitro effect of s-adenosyl methionine on ethanol embryopathy in the rat, Exp. Toxicol. Pathol., 46, 177, 10.1016/S0940-2993(11)80077-1 · DOI
- Yerby, 2003, Management issues for women with epilepsy: Neural tube defects and folic acid supplementation, Neurology, 61, S23, 10.1212/WNL.61.6_suppl_2.S23 · DOI
- Baxter, 2014, Valproate and folic acid in pregnancy: Associations with autism, Dev. Med. Child Neurol., 56, 604, 10.1111/dmcn.12498 · DOI
- Turgut, 2019, Valproic acid effect on neural tube defects is not prevented by concomitant folic acid supplementation: Early chick embryo model pilot study, Int. J. Dev. Neurosci., 78, 45, 10.1016/j.ijdevneu.2019.05.008 · DOI
- Ornoy, 2019, S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice, Neurotoxicol. Teratol., 71, 64, 10.1016/j.ntt.2018.01.005 · DOI · Paper page
- Weinstein-Fudim, L., Ergaz, Z., Turgeman, G., Yanai, J., Szyf, M., and Ornoy, A. (2019). Gender Related Changes in Gene Expression Induced by Valproic Acid in A Mouse Model of Autism and the Correction by S-adenosyl Methionine. Does It Explain the Gender Differences in Autistic Like Behavior?. Int. J. Mol. Sci., 20. · DOI · Paper page
- Pillai, 2015, Association of serum VEGF levels with prefrontal cortex volume in schizophrenia, Mol. Psychiatry, 21, 686, 10.1038/mp.2015.96 · DOI
- Lizano, 2015, Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study, Schizophr. Res., 170, 115, 10.1016/j.schres.2015.12.001 · DOI
- Lee, 2009, Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis, Eur. J. Neurol., 17, 45, 10.1111/j.1468-1331.2009.02731.x · DOI
- Mahoney, E.R., Dumitrescu, L., Moore, A.M., Cambronero, F.E., De Jager, P.L., Koran, M.E.I., Petyuk, V.A., Robinson, R.A.S., Goyal, S., and Schneider, J.A. (2019). Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease. Mol. Psychiatry. · DOI · Paper page
- Udo, 2008, Enhanced Adult Neurogenesis and Angiogenesis and Altered Affective Behaviors in Mice Overexpressing Vascular Endothelial Growth Factor 120, J. Neurosci., 28, 14522, 10.1523/JNEUROSCI.3673-08.2008 · DOI
- Weinstein-Fudim, L., Ergaz, Z., Szyf, M., and Ornoy, A. (2020). Prenatal S-Adenosine Methionine (SAMe) Induces Changes in Gene Expression in the Brain of Newborn Mice That Are Prevented by Co-Administration of Valproic Acid (VPA). Int. J. Mol. Sci., 21. · DOI
- Hollingsworth, 2008, In utero supplementation with methyl donors enhances allergic airway disease in mice, J. Clin. Investig., 118, 3462
- Jones, 1998, Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription, Nat. Genet., 19, 187, 10.1038/561 · DOI · Paper page
- Bahous, 2017, High dietary folate in pregnant mice leads to pseudo-MTHFR deficiency and altered methyl metabolism, with embryonic growth delay and short-term memory impairment in offspring, Hum. Mol. Genet., 26, 888
Cited by
Ornoy, A., Echefu, B., & Becker, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910469 · Cited by 41
Self-citation
Metadata
- Authors
- Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-25
- Volume
- 21
- Issue
- 10
- Pages
- 3721
- ISSN
- 1422-0067
- Cited by
- 31
- References
- 25
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.